MedTrace Logo

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

NCT00239135 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2015-03-25

No results posted yet for this study

Summary

The purpose of this study is :

* To determine the maximum tolerated dose (MTD) for PEP005 Topical Gel in patients with actinic keratoses.
* To evaluate patients for clinical safety
* To determine the systemic absorption of PEP005 Topical Gel

Conditions

  • Keratosis

Interventions

DRUG

PEP005

Sponsors & Collaborators

  • Peplin

    lead INDUSTRY

Principal Investigators

  • Lawrence Anderson, MD, F.A.C.P

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239135 on ClinicalTrials.gov